19-44676336-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001127893.3(CEACAM19):c.490A>T(p.Ile164Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000421 in 1,614,084 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001127893.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEACAM19 | NM_001127893.3 | c.490A>T | p.Ile164Phe | missense_variant | 3/8 | ENST00000358777.10 | NP_001121365.1 | |
CEACAM19 | NM_020219.5 | c.490A>T | p.Ile164Phe | missense_variant | 3/8 | NP_064604.2 | ||
CEACAM19 | NM_001389722.1 | c.490A>T | p.Ile164Phe | missense_variant | 4/9 | NP_001376651.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152086Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251448Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135898
GnomAD4 exome AF: 0.0000267 AC: 39AN: 1461882Hom.: 0 Cov.: 31 AF XY: 0.0000234 AC XY: 17AN XY: 727242
GnomAD4 genome AF: 0.000191 AC: 29AN: 152202Hom.: 0 Cov.: 31 AF XY: 0.000242 AC XY: 18AN XY: 74406
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 20, 2024 | The c.490A>T (p.I164F) alteration is located in exon 3 (coding exon 3) of the CEACAM19 gene. This alteration results from a A to T substitution at nucleotide position 490, causing the isoleucine (I) at amino acid position 164 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at